Invention Grant
- Patent Title: Bisphosphonate-prodrugs
- Patent Title (中): 二膦酸前体药物
-
Application No.: US14001387Application Date: 2012-02-24
-
Publication No.: US09320803B2Publication Date: 2016-04-26
- Inventor: Felix Kratz , Katrin Hochdoerffer
- Applicant: Felix Kratz , Katrin Hochdoerffer
- Applicant Address: DE Freiburg im Breisgau
- Assignee: KTB Tumorforschungsgesellschaft MBH
- Current Assignee: KTB Tumorforschungsgesellschaft MBH
- Current Assignee Address: DE Freiburg im Breisgau
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: EP11001551 20110224
- International Application: PCT/EP2012/000813 WO 20120224
- International Announcement: WO2012/113571 WO 20120830
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K47/00 ; A01N43/04 ; A61K31/70 ; A01N43/00 ; A61K31/33 ; A01N43/64 ; A61K31/41 ; A01N43/36 ; A61K31/40 ; A01N43/16 ; A61K31/35 ; C07H15/24 ; C07D345/00 ; A61K47/48 ; C07K5/062 ; C07K5/078 ; C07D405/00 ; C07H15/252 ; A61K31/704 ; A61P19/08 ; A61P35/00
Abstract:
The present invention relates to a prodrug, comprising a pharmaceutically and/or diagnostically active compound, and one or more bisphosphonate groups, to a process for producing such a prodrug, and to a pharmaceutical composition comprising said prodrug, to be used for the treatment of bone-related disorders such as bone cancer.
Public/Granted literature
- US20140051623A1 Bisphosphonate-Prodrugs Public/Granted day:2014-02-20
Information query
IPC分类:
